Search

everythinglearnresearchcommunity

for

Search:↓

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Finasteride may cause mental and sexual side effects, with hand preference and sexual orientation possibly affecting severity.

Wnt/β-catenin and TGF-β pathways affect hair loss, and activating Wnt/β-catenin could be a potential treatment.

People with X-linked hypohidrotic ectodermal dysplasia have no sweat ducts and less, thinner hair.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Mycophenolate helps reverse hair loss effects caused by IFN-γ by activating a key hair growth pathway.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Injecting CHIR-99021 into goose embryos improves feather growth by changing gene activity and energy processes.

Smoking is linked to more hair loss and premature graying compared to nonsmokers.

Cognitive-behavioral therapy with habit reversal training is the most effective treatment for trichotillomania.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

Erectile dysfunction in young men is caused by both mental and physical factors and needs a personalized treatment approach.

Mesotherapy is more effective than topical spray for female hair loss treatment.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

GLP-1 agonists may help treat certain skin conditions.

Rhamnose may help hair growth and pigmentation, making it a potential treatment for hair loss.

GRK2 is essential for healthy hair follicle function, and its absence can lead to hair loss and cysts.

The skin microbiome helps heal wounds and can be targeted to improve healing.

Pharmacists play a key role in health education and managing treatments for conditions like hair loss and smoking cessation.

Isotretinoin may cause temporary, reversible facial hair growth in some women.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Rabbits with high wool production have more hair follicles, influenced by specific long noncoding RNAs.

The decision tree can predict drug absorption issues with good accuracy but needs more validation and adjustments for other factors.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

Hair growth treatment results vary because each patient's platelets release different levels of growth factors.

PRP and LLLT can improve hair growth in AGA, but more research needed.